2022
Anesthetized Guinea Pig as a Model for Drug Testing
BARTÁKOVÁ, Anna, Marie NOVÁKOVÁ a Tibor STRAČINAZákladní údaje
Originální název
Anesthetized Guinea Pig as a Model for Drug Testing
Autoři
BARTÁKOVÁ, Anna (203 Česká republika, domácí), Marie NOVÁKOVÁ (203 Česká republika, domácí) a Tibor STRAČINA (703 Slovensko, garant, domácí)
Vydání
Physiological Research, PRAGUE, ACAD SCIENCES CZECH REPUBLIC, 2022, 0862-8408
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30105 Physiology
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.100
Kód RIV
RIV/00216224:14110/22:00128065
Organizační jednotka
Lékařská fakulta
UT WoS
000924861700006
Klíčová slova anglicky
Adrenergic agents; Animal model; Cardiovascular system; Drug testing; Guinea pig
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 5. 4. 2023 08:26, Mgr. Tereza Miškechová
Anotace
V originále
Based on the World Health Organization statistics, cardiovascular diseases represent the major cause of death worldwide. Although a wide range of treatment approaches and pharmaceuticals is available, the therapy is often not effective enough and therefore health risks for the patient persist. Thus, it is still essential to test new drug candidates for the treatment of various pathophysiological conditions related to cardiovascular system. In vivo models represent indispensable part of preclinical testing of such substances. Anesthetized guinea pig as a whole-body model allows to evaluate complex reactions of cardiovascular system to tested substance. Moreover, action potential of guinea pig cardiomyocyte is quite comparable to that of human. Hence, the results from this model are then quite well translatable to clinical medicine. Aim of this paper was to summarize the methodology of this model, including its advantages and/or limitations and risks, based on the effects of two substances with adrenergic activity on the ECG parameters. The model of anesthetized guinea pig proved to be valuable and suitable for testing of drugs with cardiovascular effects.
Návaznosti
EF19_073/0016943, projekt VaV |
| ||
MUNI/IGA/1098/2020, interní kód MU |
|